TRONTIER (trontinemab Phase 3)
Roche’s Phase 3 trontinemab programme (TRONTIER family). Confirm the current NCT on ClinicalTrials.gov before any enrollment discussion.
Overview
Seed node for the Phase 3 Brainshuttle antibody programme. Prefer the live ClinicalTrials.gov search link on the product page for exact NCT ids.
Setting
Early Alzheimer’s disease
Phase
Phase 3
Sponsor
Roche
Similar pages
not linked directly; found by shared links- TargetAmyloid-beta
Shares Trontinemab, Alzheimer’s disease and the tag dementia-atlas.
- PersonAlois Alzheimer
Shares Alzheimer’s disease and the tag dementia-atlas.
- TreatmentBrexpiprazole
Shares Alzheimer’s disease and the tag dementia-atlas.
- CollectionClinicalTrials.gov
Shares Alzheimer’s disease and the tag dementia-atlas.
- TreatmentMemantine
Shares Alzheimer’s disease and the tag dementia-atlas.
- InstitutionNational Institute on Aging
Shares Alzheimer’s disease and the tag dementia-atlas.
- TechnologyCSF amyloid and tau
Shares Alzheimer’s disease and the tag dementia-atlas.
- InstitutionUCL
Shares Alzheimer’s disease and the tag dementia-atlas.